Authors

Mikkael Sekeres, MD, MS, Cleveland Clinic

Latest:

Indiana University Researchers Find Precision Medicine Improves Outcomes

With the growing body of evidence supporting positive outcomes with the use of precision medicine–based approaches, academic cancer centers are increasingly incorporating genomic technology into standard clinical care.

MiloÅ¡ MiljkoviÄ‡, MD

Latest:

Primary Radiation Therapy for Myeloid Sarcoma of the Porta Hepatis

Treating myeloid sarcoma at the porta hepatis with 24 Gy over 12 fractions is a well-tolerated treatment that achieved a complete, durable response with minimal toxicity.

Minaxi Jhawer, MD, Englewood Hospital

Minetta Liu, MD

Latest:

Dr. Liu Describes the CellSearch CTC Test

Minetta Liu, MD, Breast Cancer Specialist, Mayo Clinic, Rochester, Minnesota, describes the CellSearch CTC Test in breast cancer.

Mira C. Hellmann, MD

Latest:

Dr. Hellmann on Using Trametinib in Low-Grade Ovarian Serous Carcinoma

Mira Hellmann, MD, discusses using trametinib to treat patients with low-grade ovarian serous carcinomas.

Mira Hellmann, MD

Latest:

Dr. Hellmann on the Impact of Systemic Therapy on Surgery in Ovarian Cancer

Mira Hellmann, MD, discusses the impact of surgery on patients with ovarian cancer.

Mishka Gidwani

Latest:

Neural "Fingerprint" Enables Personalized SBRT Dose for Lung Cancer

A prognostic, deep-learning model developed by investigators at Cleveland Clinic’s Taussig Cancer Institute in Ohio and collaborators brings radiation oncology into the realm of personalized medicine.

Missak Haigentz, MD

Latest:

Dr. Haigentz on the Importance of Adjuvant Osimertinib in EGFR+ NSCLC

Missak Haigentz Jr., MD, discusses the importance of adjuvant osimertinib in EGFR-positive non–small cell lung cancer.

Mitchel Hoffman, MD

Latest:

Dr. Hoffman on Research Regarding Neoadjuvant Chemo and Primary Debulking in Ovarian Cancer

Mitchel Hoffman, MD, gynecologic oncologist, Moffitt Cancer Center, discusses ongoing research regarding neoadjuvant chemotherapy and primary debulking surgery in advanced ovarian cancer.

Mitchell Benson, MD

Latest:

Dr. Benson on Extensive Biopsies for Low-Risk Prostate Cancer

Mitchell Benson, MD, the Herbert and Florence Irving Professor at Columbia University Medical Center, New York-Presbyterian Hospital, discusses extensive biopsies in low-risk patients with prostate cancer.

Mitchell C. Benson MD, PhD

Latest:

Molecular Signature Distinguishes Indolent From Aggressive Prostate Cancer

Prostate cancer is one of the most common forms of cancer in older men, with more than 200,000 new diagnoses per year.

Mitchell R. Smith, MD, PhD

Latest:

Dr. Smith on the Patient Population of the ECOG-ACRIN E1411 Trial in MCL

Mitchell R. Smith, MD, PhD, discusses the patient population of the phase 2 ECOG-ACRIN E1411 trial in mantle cell lymphoma.

Mitesh J. Borad, MD

Latest:

Dr Borad on the Initial Efficacy of RLY-4008 in FGFR2 Fusion–Positive Cholangiocarcinoma

Mitesh Borad, MD, key findings from the phase 1/2 ReFocus trial in FGFR2-altered cholangiocarcinoma.

Moben Mirza, MD

Latest:

Dr. Mirza on Hematuria and a Bladder Cancer Diagnosis

Moben Mirza, MD, assistant professor of urology at the University of Kansas Medical Center, discusses a study presented at the 2014 AUA Annual Meeting that evaluated gender and race variation in the workup of hematuria.

Mohamed Abazeed, MD, PhD

Latest:

Neural "Fingerprint" Enables Personalized SBRT Dose for Lung Cancer

Mohamed Abdel Khalek, MD

Latest:

Battling Burnout: Advice On Preventing and Dealing with Burnout in Your Future Career

A career in oncology can be a tremendously fulfilling and a meaningful venture. Oncologists care for the sick, advance medical science, and mentor the next generation of medical professionals.

Mohamed Akkad, MD

Latest:

Hemophagocytic Lymphohistiocytosis in a Patient With Nodular Lymphocyte–Predominant Hodgkin Lymphoma: A Case Report

This is the first case report of hemophagocytic lymphohistiocytosis complicating a nodular lymphocyte–predominant Hodgkin lymphoma in an adult treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone.

Mohamed E. Abazeed, MD, PhD

Latest:

Cleveland Clinic Researchers Explore Genetic Landscape of Radiotherapeutic Resistance

Priyanka Gopal, MD, and Mohamed E. Abazeed, MD, PhD, discuss radiotherapy in the era of precision medicine.

Mohamed E. Salem, MD

Latest:

Dr. Salem on the Results of the MyPathway Trial in mCRC

Mohamed E. Salem, MD, a medical oncologist at Levine Cancer Institute, Atrium Health, discusses the results of the MyPathway trial in metastatic colorectal cancer (mCRC).